Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Vanderschueren

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie|April 19, 2000
[Staphylokinase for a better thrombolytic treatment of heart and platelet diseases]S Vanderschueren
Acta Clinica Belgica|October 9, 2009
General internal medicine in Belgium: to be or not to be?S Vanderschueren,
Acta Clinica Belgica|September 2, 2014
Tackling fever and inflammation of unknown origin: the do's and don'tsS Vanderschueren, D Knockaert
Thrombosis and Haemostasis|May 1, 1996
Comparative effects of staphylokinase and alteplase in rabbit bleeding time modelsS Vanderschueren, D Collen
Acta Clinica Belgica|February 18, 2012
The haemophagocytic syndromeD Dierickx, A Cortoos, S Vanderschueren
Acta Clinica Belgica|January 1, 1994
Is BCG vaccination against tuberculosis still indicated?S Vanderschueren, W Peetermans, H Bobbaers
European Journal of Internal Medicine|October 10, 2018
Appropriateness of ordering serum angiotensin-converting enzyme during renin-angiotensin-aldosterone system inhibitor therapyA Betrains, P Vermeersch, S Vanderschueren
Seminars in Arthritis and Rheumatism|June 6, 2020
Efficacy and safety of canakinumab treatment in schnitzler syndrome: A systematic literature reviewA Betrains, F Staels, S Vanderschueren
Journal of Cardiovascular Pharmacology|June 1, 1996
Comparative antigenicity of recombinant wild-type staphylokinase (SakSTAR) and a selected mutant (SakSTAR.M38) in a baboon thrombolysis modelS Vanderschueren, J M Stassen, D Collen
Stroke|September 26, 1997
Intravenous thrombolysis with recombinant staphylokinase versus tissue-type plasminogen activator in a rabbit embolic stroke modelS Vanderschueren, I Van Vlaenderen, D Collen
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie|April 19, 2000
[Staphylokinase for a better thrombolytic treatment of heart and platelet diseases]S Vanderschueren
Acta Clinica Belgica|October 9, 2009
General internal medicine in Belgium: to be or not to be?S Vanderschueren,
Acta Clinica Belgica|September 2, 2014
Tackling fever and inflammation of unknown origin: the do's and don'tsS Vanderschueren, D Knockaert
Thrombosis and Haemostasis|May 1, 1996
Comparative effects of staphylokinase and alteplase in rabbit bleeding time modelsS Vanderschueren, D Collen
Acta Clinica Belgica|February 18, 2012
The haemophagocytic syndromeD Dierickx, A Cortoos, S Vanderschueren
Acta Clinica Belgica|January 1, 1994
Is BCG vaccination against tuberculosis still indicated?S Vanderschueren, W Peetermans, H Bobbaers
European Journal of Internal Medicine|October 10, 2018
Appropriateness of ordering serum angiotensin-converting enzyme during renin-angiotensin-aldosterone system inhibitor therapyA Betrains, P Vermeersch, S Vanderschueren
Seminars in Arthritis and Rheumatism|June 6, 2020
Efficacy and safety of canakinumab treatment in schnitzler syndrome: A systematic literature reviewA Betrains, F Staels, S Vanderschueren
Journal of Cardiovascular Pharmacology|June 1, 1996
Comparative antigenicity of recombinant wild-type staphylokinase (SakSTAR) and a selected mutant (SakSTAR.M38) in a baboon thrombolysis modelS Vanderschueren, J M Stassen, D Collen
Stroke|September 26, 1997
Intravenous thrombolysis with recombinant staphylokinase versus tissue-type plasminogen activator in a rabbit embolic stroke modelS Vanderschueren, I Van Vlaenderen, D Collen
Pageof 6